FDA approves new drug for hot flashes. Why it shows 'a lot of promise'

The Food and Drug Administration on Friday approved fezolinetant, or Veozah, to treat hot flashes for women in menopause. The non-hormonal drug treatm

Related Keywords

West Virginia ,United States ,Morgantown ,Astellas Pharma ,Roberta Renzelli Cain ,Katherine Scruggs ,School Of Medicine ,Allegheny Health Network Midlife Women Associates ,Drug Administration On ,University Of Pittsburgh Department Women Health ,Drug Administration ,Beth Prairie ,Allegheny Health Network Midlife Women ,West Penn ,Japan Based Astellas Pharma ,Pittsburgh Department ,